Assertio to Participate in AGP Healthcare Conference on May 21
May 16 2024 - 9:16AM
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq:
ASRT), a pharmaceutical company with comprehensive commercial
capabilities offering differentiated products to patients, today
announced that Ajay Patel, Chief Financial Officer, will present at
the Alliance Global Partners Virtual Healthcare Company Showcase to
be held virtually on May 21, 2024. Mr. Patel will present an
overview of Assertio’s business at 3:40 p.m. Eastern Time.
The event is hosted by AGP’s healthcare equity research team.
Investors interested in joining the conference can request to do so
via their AGP representative, or contact Assertio investor
relations via mkreps@darrowir.com.
Presentation information will be available on the day of the
event and can accessed at https://investor.assertiotx.com.
About Assertio
Assertio is a commercial pharmaceutical company offering
differentiated products to patients. We have built our commercial
portfolio through acquisition or licensing of approved products.
Our comprehensive commercial capabilities include marketing through
both a sales force and a non-personal promotion model, market
access through payor contracting, and trade and distribution. To
learn more about Assertio, visit www.assertiotx.com.
Forward Looking Statements
Statements in this communication that are not historical facts
are forward-looking statements that reflect Assertio’s current
expectations, assumptions and estimates of future performance and
economic conditions. These forward-looking statements are made in
reliance on the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking
statements relate to, among other things, future events or the
future performance or operations of Assertio, including risks
related to our ability to realize the benefits from our operating
model, successfully integrate new assets, explore new business
development initiatives, and successfully recruit a successor CEO
on a timely basis. All statements other than historical facts may
be forward-looking statements and can be identified by words such
as “anticipate,” “believe,” “could,” “design,” “estimate,”
“expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,”
“objective,” “opportunity,” “outlook,” “plan,” “position,”
“potential,” “predict,” “project,” “prospective,” “pursue,” “seek,”
“should,” “strategy,” “target,” “would,” “will,” “aim” or other
similar expressions that convey the uncertainty of future events or
outcomes and are used to identify forward-looking statements. Such
forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties and other factors, some of
which are beyond the control of Assertio, including the risks
described in Assertio’s Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q filed with the U.S. Securities and Exchange
Commission (“SEC”) and in other filings Assertio makes with the SEC
from time to time. Investors and potential investors are urged not
to place undue reliance on forward-looking statements in this
communication, which speak only as of this date. While Assertio may
elect to update these forward-looking statements at some point in
the future, it specifically disclaims any obligation to update or
revise any forward-looking-statements contained in this press
release whether as a result of new information or future events,
except as may be required by applicable law.
Investor Contact
Matt Kreps, Managing DirectorDarrow AssociatesM:
214-597-8200mkreps@darrowir.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Aug 2023 to Aug 2024